remark
aut
hor
wang
et
al
develop
drug
screen
syst
em
wit
h
human
report
er
cell
line
found
compound
increas
prot
ein
level
flow
present
ed
manuscript
st
raight
forward
easi
underst
unfort
unat
eli
novelt
st
rong
term
screen
st
rat
egi
find
enhanc
express
previous
discuss
elsewher
eg
drug
mar
j
biomol
screen
apr
et
c
invest
igat
ion
moa
lead
compound
limit
ed
suffici
alt
hough
approach
int
erest
ing
sever
issu
resolv
scient
ific
signific
major
point
evaluat
ion
ht
assay
syst
em
insuffici
posit
ive
cont
rol
lack
informat
ion
ht
met
hod
poor
aut
hor
describ
use
fluoresc
microscopi
name
light
sourc
writ
ten
met
hod
wit
hout
explanat
ion
ht
syst
em
unclear
ht
conduct
ed
fluoresc
int
ensit
i
evaluat
ed
use
imag
j
aut
ofluoresc
dead
cell
dist
inguish
furt
hermor
result
screen
show
poor
reproducibilit
present
ed
figur
hit
compound
show
increas
prot
ein
west
ern
blot
ting
express
pat
tern
might
complet
eli
differ
pat
ient
fibroblast
anim
model
pat
ient
could
possibilit
abnorm
karyot
ype
includ
locu
aft
er
longt
ime
passag
aut
hor
use
pat
ient
fibroblast
confirm
therapeut
ic
effect
hit
compound
cont
rol
fibroblast
set
time
aut
hor
describ
zfafmk
could
elongat
e
life
span
sma
model
mice
result
sect
ion
howev
zfafmk
show
posit
ive
effect
mous
surviv
wit
h
st
ist
ical
signific
furt
hermor
unclear
hit
compound
select
ed
next
vivo
experi
even
though
sever
cyst
ein
prot
eas
inhibit
or
aut
hor
present
rat
ionalit
det
ail
met
hod
vivo
experi
lack
aut
hor
describ
inject
ed
zfafmk
int
lat
eral
cerebr
vent
ricl
post
nat
al
day
day
mice
also
decid
dose
compound
unclear
whet
amount
zfafmk
ng
microm
microl
per
day
appropriat
e
treat
ment
author
investig
protein
level
spinal
cord
smn
model
mice
treat
ment
wit
h
zfafmk
clarifi
poc
vivo
minor
point
qualit
imag
show
alt
ere
gfp
signal
poor
wit
h
high
background
nois
aut
hor
bet
ter
use
luc
report
er
syst
em
aut
hor
add
graph
show
screen
result
plot
ting
alt
ere
rat
io
compar
wit
h
dmso
cont
rol
compound
figur
west
ern
blot
ting
band
appropriat
e
gapdh
band
also
alt
ere
addit
ion
compound
includ
compound
chang
aut
hor
also
add
calculat
ed
dat
show
chang
figur
charact
erizat
ion
differ
iat
ed
mot
neuron
lack
aut
hor
add
informat
ion
cellspecif
marker
purit
percent
age
per
dapi
et
c
figur
band
act
also
alt
ere
ad
zfafmk
remark
aut
hor
wang
et
al
generat
ed
human
report
er
cell
line
perform
hight
hroughput
screen
ident
ifi
candidat
es
could
increas
smn
prot
ein
level
especi
found
irrevers
inhibit
cyst
ein
prot
eas
z
fafmk
effect
ive
candidat
e
furt
test
ed
effect
zfafmk
pat
ient
ipsc
ipscsderiv
mot
neuron
found
relat
ed
proteasedegradat
ion
pat
hway
inhibit
ion
furt
hermor
aut
hor
demonst
rat
ed
cyst
ein
prot
eas
ctsl
import
ant
mediat
ing
smn
prot
ein
degradat
ion
cellular
phenot
ype
smn
abnorm
mit
ochondria
behavior
neuron
degenerat
ion
mot
neuron
also
rescu
zfafmk
treat
ment
final
demonst
rat
ed
zfafmk
anot
cyst
ein
prot
eas
inhibit
prot
ect
ive
effect
sma
anim
model
overal
st
udi
well
organ
clearli
present
ed
conclus
st
rongli
support
ed
result
minor
comment
includ
quantif
data
shown
author
indic
mean
plu
minu
sem
shown
inform
replicaten
number
quantif
provid
figur
time
point
stage
also
clearli
state
either
figur
legend
figur
author
identifi
cystein
proteas
ctsl
import
regul
smn
protein
stabil
howev
effect
zfafmk
specif
proteas
examin
discuss
figur
figur
difficult
understand
author
clearli
explain
result
figur
mitochondria
transport
neuron
degener
examin
confirm
function
relev
smn
protein
stabil
mediat
zfafmk
ideal
neuron
activ
examin
eventu
confirm
function
relev
author
discuss
figur
b
although
decreas
motor
neuron
smadmso
group
proport
dapi
nuclei
look
similar
ie
similar
number
total
cell
still
grow
condit
author
address
effect
differenti
variationsmotor
neuron
puriti
among
differ
group
quantif
similar
issu
figur
figur
author
may
also
enlarg
part
figur
better
display
axon
swell
breakdown
figur
wt
control
besid
dapi
stain
total
nuclei
aut
hor
quant
ifi
percent
age
posit
ive
cell
figur
remark
aut
hor
manuscript
drug
screen
wit
h
human
report
er
ident
ifi
smn
prot
ein
st
abil
correct
sma
pat
holog
describ
const
ruct
ion
report
er
cell
line
applicat
ion
screen
compound
hat
correct
skip
common
caus
sma
modest
scale
screen
ident
ifi
compound
z
fafmk
cyst
ein
prot
eas
inhibit
increas
amount
z
fafmk
posit
ive
effect
smn
st
abilit
sever
phenot
ypic
measur
includ
sma
pat
ient
ipscderiv
mot
neuron
well
small
increas
surviv
sma
mice
model
manuscript
includ
sever
int
erest
ing
observat
ion
howev
view
add
signific
advanc
quest
ion
remain
unaddress
sever
concern
suscept
ibilit
prot
eas
previous
elucidat
ed
pot
ent
ial
inhibit
or
process
sma
previous
propos
st
udi
burnet
fishbeck
dreyfuss
rubin
laborat
ori
prot
eas
inhibit
or
z
fafmk
like
pleiot
ropic
effect
rat
han
select
ive
effect
need
invest
igat
ed
syst
emat
ical
exampl
mass
spect
romet
ry
possibl
ever
effect
zfafmk
may
unrelat
ed
smn
increas
delet
eriou
cell
organ
longer
erm
experi
comment
similar
report
er
screen
sma
previous
describ
aut
hor
seem
nice
set
may
use
larger
scale
screen
thank
transfer
manuscript
entitl
drug
screen
human
report
identifi
smn
protein
stabil
correct
sma
patholog
life
scienc
allianc
manuscript
assess
expert
review
anoth
journal
editor
transfer
report
us
permiss
furthermor
alreadi
provid
outlin
could
address
main
concern
review
review
thought
work
wellexecut
note
similar
approach
use
insight
smn
stabil
occur
lack
concern
public
would
thu
like
invit
provid
revis
version
manuscript
pleas
provid
pointbypoint
respons
concern
rais
includ
inform
addit
data
alreadi
outlin
upfront
provid
upfront
editori
assess
pleas
also
make
sure
adequ
describ
ht
method
review
add
request
quantif
potenti
pleiotrop
effect
proteas
inhibitor
furthermor
get
mention
manuscript
text
upload
revis
version
manuscript
pleas
log
account
http
lsamsubmitnetcgibinmainplex
guid
complet
submiss
revis
manuscript
fill
necessari
inform
revis
manuscript
pleas
also
attend
editori
point
help
expedit
public
manuscript
pleas
direct
editori
question
journal
offic
thank
interest
contribut
life
scienc
allianc
look
forward
receiv
revis
manuscript
sincer
andrea
leibfri
phd
execut
editor
life
scienc
allianc
meyerhofstr
heidelberg
germani
e
aleibfri
lifescienceallianceorg
wwwlifescienceallianceorg
letter
address
review
comment
point
point
edit
version
final
text
doc
docx
need
copyedit
pdf
highresolut
figur
supplementari
figur
video
file
upload
individu
file
see
detail
guidelin
prepar
productionreadi
imag
http
lifescienceallianceorgauthorguid
summari
blurb
enter
submiss
system
short
text
summar
singl
sentenc
studi
max
charact
includ
space
text
use
conjunct
titl
paper
henc
inform
complementari
titl
run
titl
describ
context
signific
find
gener
readership
written
present
tens
refer
work
third
person
author
name
mention
full
guidelin
avail
instruct
author
page
http
lifescienceallianceorgauthorguid
encourag
author
provid
origin
sourc
data
particularli
uncroppedprocess
electrophoret
blot
spreadsheet
main
figur
manuscript
would
like
add
sourc
data
would
welcom
one
pdfexcelfil
per
figur
inform
file
link
onlin
supplementari
sourc
data
file
import
life
scienc
allianc
polici
request
origin
data
imag
must
made
avail
failur
provid
origin
imag
upon
request
result
unavoid
delay
public
pleas
ensur
access
origin
microscopi
blot
data
imag
submit
revis
author
respons
review
februari
major
concern
review
suscept
smn
protein
proteas
previous
elucid
though
previou
studi
examin
stabil
smn
protein
focus
ubiquitin
proteasom
calpain
summar
follow
tabl
instead
examin
two
major
famili
cystein
proteinas
studi
effect
systemat
multipl
angl
first
perform
screen
proteas
use
rnai
fig
evalu
candid
use
coimmunoprecipit
western
blot
exam
bind
smn
isoform
fig
final
examin
degrad
smn
protein
overexpress
cystein
proteas
use
induc
fig
fig
data
show
nonlysosom
ie
calpain
lysosom
cystein
proteas
eg
ctslctsb
degrad
smnfull
length
data
signific
except
calpain
role
degrad
smn
protein
report
moreov
cathepsin
ctsbctsl
belong
lysosom
cystein
proteas
lysosom
dysfunct
implic
mani
neurolog
diseas
thu
demonstr
smn
protein
degrad
nonlysosom
lysosom
cystein
proteas
either
direct
bind
mechan
includ
lysosomalmedi
pathway
provid
novel
target
regul
smn
protein
cherri
et
al
rietz
et
al
work
show
smn
proteolyt
target
calpain
alln
use
tool
inhibit
calpain
effect
test
sma
cell
anim
model
exogen
calpain
also
use
fuent
et
al
clear
perform
addit
experi
examin
data
reveal
signific
increas
number
ventral
horn
motor
neuron
lumbar
segment
zfafmk
treatment
coincid
signific
increas
smn
protein
spinal
cord
tissu
treatment
fig
signific
advantag
previou
studi
calpain
smn
fuent
et
al
effect
inhibit
cystein
proteas
studi
cell
anim
sma
model
new
data
confirm
efficaci
zfafmk
sma
mice
vivo
provid
novel
target
approach
treat
sma
sinc
pass
bbb
easi
administ
neonat
mice
drug
inject
sma
mice
daili
everi
day
start
day
may
show
stronger
effect
zfafmk
longterm
significantli
increas
life
span
sma
mice
nevertheless
zfafmk
treat
day
show
trend
increas
life
span
sma
mice
zfafmk
significantli
increas
proport
spinal
motor
neuron
spinal
cord
section
day
sma
mice
fig
data
togeth
demonstr
effect
candid
compound
vivo
suggest
novel
approach
treat
sma
target
cystein
proteas
potent
inhibitor
thiol
proteas
includ
ctsb
hook
et
al
inubushi
et
al
romin
et
al
trinches
et
al
tsubokawa
et
al
also
prove
safe
human
shown
clinic
studi
alzheim
diseas
traumat
brain
injuri
trial
stop
lack
efficaci
drug
proven
safe
human
given
significantli
increas
protein
level
smn
surviv
spinal
motor
neuron
life
span
sma
mice
vivo
studi
identifi
novel
target
regul
smn
protein
also
provid
new
candid
therapeut
agent
sma
tabl
summar
previou
studi
relat
suscept
protein
upregul
smn
protein
sma
see
though
previou
studi
shown
protein
suscept
degrad
focus
proteasom
pathway
phosphoryl
autophagi
studi
show
role
cystein
proteas
smn
degener
strayer
group
calpain
studi
furthermor
protect
effect
motor
neuron
degener
cystein
proteas
inhibitor
examin
review
manuscript
studi
report
examin
role
calpain
sma
model
de
la
fuent
et
al
examin
cathepsin
lysosomaldepend
proteas
includ
discuss
studi
discuss
section
revis
manuscript
work
novel
signific
follow
aspect
first
work
show
nonlysosom
eg
lysosom
cystein
proteinas
eg
ctslctsb
mediat
degrad
smn
protein
demonstr
novel
effect
zfafmk
two
cystein
proteas
inhibitor
increas
smn
protein
sma
model
vitro
vivo
reveal
efficaci
zfafmk
rescu
motor
neuron
loss
ipscbas
cultur
model
sma
mous
model
also
significantli
increas
life
span
sma
mice
togeth
work
demonstr
novel
role
cystein
proteas
nonlysosom
lysosom
cystein
proteas
regul
smn
protein
stabil
reveal
novel
target
candid
rescu
motor
neuron
degener
treatment
sma
review
evalu
ht
assay
system
insuffici
posit
control
lack
inform
ht
method
poor
thank
point
includ
detail
descript
drug
screen
method
method
section
examin
posit
control
fig
author
describ
zfafmk
could
elong
life
span
sma
model
mice
result
section
howev
zfafmk
show
posit
effect
mous
surviv
statist
signific
furthermor
unclear
hit
compound
select
next
vivo
experi
even
though
sever
cystein
proteas
inhibitor
modifi
descript
text
zfafmk
show
trend
increas
life
span
sma
mice
sinc
zfafmk
could
pass
bbb
compound
administr
sma
mice
short
period
time
select
drug
pass
bbb
prove
safe
previou
clinic
trial
inde
significantli
mitig
motor
neuron
degener
increas
life
span
sma
mice
see
address
major
concern
detail
protect
effect
ad
relat
inform
revis
manuscript
detail
method
vivo
experi
lack
author
describ
inject
zfafmk
later
cerebr
ventricl
postnat
day
day
mice
also
decid
dose
compound
unclear
whether
amount
zfafmk
ng
microm
microl
per
day
appropri
treatment
detail
ad
revis
manuscript
method
section
result
section
concentr
zfafmk
use
icv
inject
base
amount
anoth
paper
hara
et
al
also
cite
revis
paper
author
investig
protein
level
spinal
cord
smn
model
mice
treatment
zfafmk
clarifi
poc
vivo
thank
great
suggest
examin
protein
sma
mice
found
zfafmk
significantli
increas
protein
level
smn
protein
fig
g
qualiti
imag
show
alter
gfp
signal
poor
high
background
nois
author
better
use
luc
report
system
gfp
signal
repres
protein
degrad
fast
therefor
gfp
signal
weak
cell
measur
gfp
fluoresc
imagej
softwar
alway
consid
calcul
background
intens
remov
cellular
signal
well
futur
replac
gfp
luciferas
improv
system
author
add
graph
show
screen
result
plot
alter
ratio
compar
dmso
control
compound
includ
graph
show
screen
result
identifi
compound
could
brighten
gfp
fluoresc
compar
dmsotreat
cell
fig
figur
western
blot
band
appropri
gapdh
band
also
alter
addit
compound
includ
compound
chang
author
also
add
calcul
data
show
chang
gapdh
alter
attribut
bia
load
sampl
rather
addit
compound
perform
western
blot
quantifi
data
shown
figur
rel
level
smn
protein
compar
gapdh
protein
util
comparison
elimin
variat
caus
load
differ
amount
sampl
quantif
data
compound
effect
hit
increas
endogen
smn
protein
type
sma
fibroblast
cell
figur
character
differenti
motor
neuron
lack
protocol
base
wellestablish
protocol
previous
examin
character
motor
neuron
differenti
sma
ipsc
xu
et
al
describ
work
detail
ad
detail
inform
minor
point
figur
band
actin
also
alter
ad
zfafmk
accur
quantifi
protein
level
actin
use
load
control
compar
differ
group
level
smn
protein
rel
actin
protein
compar
differ
group
elimin
variat
caus
differ
load
amount
sampl
also
statist
analyz
quantif
data
differ
group
observ
dosedepend
increas
smn
protein
zfafmk
quantif
data
shown
author
indic
mean
sem
shown
inform
replicaten
number
quantif
provid
thank
bring
includ
inform
figur
legend
figur
time
point
stage
also
clearli
state
either
figur
legend
ad
inform
figur
legend
figur
author
identifi
cystein
proteas
ctsl
import
regul
smn
protein
stabil
howev
effect
zfafmk
specif
proteas
examin
discuss
thank
great
suggest
discuss
section
address
major
concern
examin
role
cystein
proteas
multipl
angl
identifi
lysosom
nonlysosom
proteas
mediat
degrad
smn
protein
examin
effect
zfafmk
proteas
observ
inhibit
smn
protein
degrad
zfafmk
overexpress
cystein
proteas
fig
figur
figur
difficult
understand
author
clearli
explain
result
figur
imag
repres
posit
xaxi
versu
time
yaxi
kymograph
xaxi
kymograph
repres
posit
along
neuron
axon
yaxi
repres
durat
detect
mitochondri
movement
ie
minut
line
imag
repres
mitochondrion
mitochondrion
move
imag
chang
posit
along
xaxi
lead
vertic
line
repres
imag
could
see
less
vertic
line
smazfafmk
group
compar
smadmso
group
suggest
increas
mitochondri
transport
zfafmk
detail
explan
ad
figur
mitochondria
transport
neuron
degener
examin
confirm
function
relev
smn
protein
stabil
mediat
zfafmk
ideal
neuron
activ
examin
eventu
confirm
function
relev
author
discuss
discuss
futur
examin
neuron
activ
discuss
section
figur
b
although
decreas
motor
neuron
smadmso
group
proport
dapi
nuclei
look
similar
ie
similar
number
total
cell
still
grow
condit
author
address
effect
differenti
variat
motor
neuron
puriti
among
differ
group
quantif
sma
character
specif
degener
spinal
motor
neuron
report
initi
specif
spinal
motor
neuron
lineag
affect
sma
group
initi
motor
neuron
proport
similar
control
sma
group
effici
gener
motor
neuron
progenitor
observ
group
ensur
rigor
comparison
multipl
region
select
blindli
triplic
sampl
describ
degener
spinal
motor
neuron
happen
longterm
cultur
eg
chang
morpholog
accumul
swell
support
increas
apoptosi
longterm
cultur
fig
describ
detail
revis
manuscript
figur
author
may
also
enlarg
part
figur
better
display
axon
swell
breakdown
enlarg
part
includ
show
axon
swell
breakdown
figur
wt
control
besid
dapi
stain
total
nuclei
author
quantifi
percentag
posit
cell
figur
thank
point
wt
group
would
shown
zfafmk
treatment
focus
compar
vehicleand
group
ye
nuclei
stain
hoechst
perform
includ
show
two
stain
clear
also
includ
hoechst
imag
review
suscept
proteas
previous
elucid
potenti
inhibitor
process
sma
previous
propos
studi
burnettfishbeck
dreyfuss
rubin
laboratori
though
suscept
proteas
previous
elucid
previou
studi
focus
ubiquitin
proteasom
calpain
pleas
see
summar
tabl
addit
calpain
data
identifi
novel
role
nonlysosom
eg
calpain
lysosom
cystein
proteas
eg
ctsbctsl
degrad
smn
protein
fig
fig
high
import
member
differ
calpain
uniqu
role
patholog
condit
pleas
see
section
address
major
concern
review
detail
inform
previou
studi
find
proteas
inhibitor
zfafmk
like
pleiotrop
effect
rather
select
effect
possibl
whatev
effect
zfafmk
may
specif
proteas
unrel
smn
increas
deleteri
cell
organ
longer
term
experi
thank
bring
great
point
one
candid
compound
use
clinic
trial
alzheim
diseas
traumat
brain
injuri
medtrack
drug
approv
safe
human
trial
stop
lack
efficaci
studi
significantli
increas
protein
level
smn
surviv
spinal
motor
neuron
life
span
sma
mice
vivo
suggest
serv
new
candid
therapeut
agent
sma
includ
discuss
issu
revis
manuscript
